logo
Select company
Select metric
$ -84.31MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
9
Sector
22
Industry
33
History
-
$ 22.57Close
$ 5.02 - $ 27.09 52-Week Range
Ticker Information

Ticker

SEPN

Company Name

SEPTERNA INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

SEPTERNA INC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

SEPN - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 3.49M$ -87.8M$ -84.31M
12/31/2024$ 2.78M$ -72.3M$ -69.51M
12/31/2023$ 1.66M$ 4.87M$ 6.53M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • SEPTERNA INC's latest trailing twelve months (TTM) EBITDA stands at $ 6.53M.
  • Over the past 5 years, SEPTERNA INC's average EBITDA has been $ -49.1M.
  • The median EBITDA for SEPTERNA INC during this period was $ -69.51M
  • SEPTERNA INC reached its highest EBITDA over the past 5 years at $ 6.53M.
  • The lowest EBITDA recorded by SEPTERNA INC in the same timeframe $ -84.31M

SEPTERNA INC's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
PROK : PROKIDNEY CORP $ -65.55MHUMA : HUMACYTE INC $ -40.8MABEO : ABEONA THERAPEUTICS INC $ 79.97MMREO : MEREO BIOPHARMA GROUP PLC $ -49.23MCRDF : CARDIFF ONCOLOGY INC $ -50.37MNWBO : NORTHWEST BIOTHERAPEUTICS INC $ -72.28MRNAC : CARTESIAN THERAPEUTICS INC $ -31.76MVTGN : VISTAGEN THERAPEUTICS INC $ -55.12MRNXT : RENOVORX INC $ -11MATYR : ATYR PHARMA INC $ -65.48M

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA
EBITDA for SEPTERNA INC is calculated as follows: EBIT [ $ 4.87M ] + DepAmor [ $ 1.66M ]
(=) EBITDA [ $ 6.53M ]

SEPN - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -84.31M

Minimum

Jun 30, 2025

$ 6.53M

Maximum

Dec 31, 2023

$ -49.1M

Average

$ -69.51M

Median

EBITDA Benchmark Analysis

The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.8M with a standard deviation of $ 166.97M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.25K
min$ -493.3M
max$ 590.6M
average$ 58.8M
median$ 8.83M
std$ 166.97M